The Pitt Street Research valuation range for PSC from 5 November 2019 was at A$0.44 per share base case and A$0.93 per share optimistic case, including all the risks, like Arcadia project beeing in Zimbabwe...
"... A steady growth in lithium prices, further progress on the Arcadia development plan and clarity on project funding will help drive favourable sentiment and re-rate the stock into our valuation range..."
Since our NPV is increased by 39%, their new valuation range would be from A$0.61 to A$1.29.
I think we will get to this range as soon as PSC announces the US$162 Mio. funding path, be it with a mix of debt/equity with an African Development Bank, Uranium One...
This is my personal opinion only and it is not financial advice. Do your own research.
- Forums
- ASX - By Stock
- PSC
- Value per share ?
Value per share ?, page-3
Featured News
Add PSC (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
-0.015(10.7%) |
Mkt cap ! $64.62M |
Open | High | Low | Value | Volume |
14.0¢ | 14.0¢ | 11.5¢ | $125.9K | 974.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 79999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.120 |
3 | 163000 | 0.115 |
3 | 35000 | 0.100 |
1 | 71195 | 0.090 |
1 | 6868 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 79999 | 1 |
0.135 | 25000 | 1 |
0.145 | 10000 | 1 |
0.150 | 105000 | 2 |
0.155 | 46500 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
PSC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online